Robert I. Blum, President & CEO at CYTOKINETICS INC (CYTK), sold 5,000 shares at $60.03 ($300K) on 2025-10-16, disclosed to the SEC on 2025-10-16.
Scheduled sale ($300k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2026-09-15 | $7.3M | — | Filing → |
| CYTK | SELL | 2026-08-31 | $527K | — | Filing → |
| CYTK | SELL | 2026-08-10 | $576K | — | Filing → |